Role of Cul4A in Governing Th2-Type Tolerance
Cul4A 在控制 Th2 型耐受中的作用
基本信息
- 批准号:10198025
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAirway DiseaseAllergic DiseaseAllergic inflammationAsthmaAutoimmune DiseasesCD4 Positive T LymphocytesCell physiologyCellsChromatinDevelopmentEvolutionExhibitsExtrinsic asthmaFamilyGene Expression Microarray AnalysisGenerationsGenesGoalsHematopoieticHumanIgEIgG1Immune System DiseasesImmune ToleranceImmune responseIn VitroInfiltrationInflammationInflammatoryInflammatory ResponseInterleukin-2Interleukin-4Knock-outKnockout MiceMediatingMethodsModelingMolecularMusPathogenesisPeripheralPhenotypePhysiologicalPreventionProductionPropertyReagentRegulationRegulatory T-LymphocyteResearchRoleSiteT cell regulationT-Cell ActivationT-Cell ProliferationT-LymphocyteTechnologyTh1 CellsTh2 CellsTherapeuticWorkairway inflammationallergic airway inflammationallergic responseasthmatic patientbasecell typecytokineeffector T cellin vivoin vivo Modelinsightknock-downnoveloral toleranceoverexpressionpreventrespiratoryresponsescreeningsmall hairpin RNAubiquitin-protein ligaseyeast two hybrid system
项目摘要
PROJECT SUMMARY/ABSTRACT
The hallmark of allergic diseases is the infiltration/accumulation of Th2 cells at the sites of inflammation;
however the mechanisms governing the development of unwanted Th2-driven airway diseases are poorly
understood. Thus, today it is becoming clear that understanding the Th2-type immune responses and ways
to control them may prove to be invaluable for the treatment of allergic inflammation.
Recently, we as well as others, have demonstrated the role of E3 ubiquitin ligases in T cell tolerance.
Cullin4A (Cul4A) belongs to the evolutionally conserved E3 ligase family and has been suggested to be
involved in hematopoietic cell activation and in chromatin regulation; however, the role of Cul4A in T
lymphocytes has not been addressed yet. Interestingly, expression of Cul4A was upregulated in tolerant T
cells. Moreover, Cul4A knockout (KO) CD4+ T cells activated in vitro and in vivo under tolerogenic conditions
exhibited an enhanced level of proliferation along with IL-2 and IL-4 production compared to wild-type cells,
suggesting an important role of Cul4A in regulation of T cell tolerance. Strikingly, we found that Cul4A KO
effector T cells and Treg cells expressed higher levels of Th2 but not Th1 and Th17 cytokines, which correlates
with increased levels of IgG1 and IgE in the sera of Cul4A KO mice, indicating the selective role of Cul4A in
controlling inflammatory Th2-type responses. Importantly, we detected reduced Cul4A expression in CD4+ T
cells from asthmatic patients compared to CD4+ T cells from healthy donors, further indicating that Cul4A
potentially contributes to airway immune tolerance induction. In addition, shRNA knockdown of Cul4A in
human CD4+ T cells resulted in upregulated expression of Th2-specific cytokines. Based on these findings, we
hypothesize that regulation of Th2-type immune responses by Cul4A may be an important checkpoint
in airway tolerance induction, which is crucial to prevent development of allergic diseases.
In Aim 1, we propose to determine the mechanisms whereby Cul4A controls T cell activation by utilizing
gene knockdown approaches and in vitro and in vivo Th2 tolerance induction models. In Aim 2, we will
determine the role of Cul4A in Th2 cell programming and its underlying mechanisms as well. We will employ
cutting edge technologies, including two-hybrid screening and microarray analysis of gene expression, to
identify the exact target(s) of Cul4A to determine its function in Th2 development. In addition, we will assess
the cellular mechanisms whereby Cul4A controls Th2 type-driven allergic asthma. In Aim 3, we will determine
the mechanism by which Cul4A regulates Treg function, particularly in controlling Th2 inflammatory
responses. The physiological significance of this finding will be analyzed in different in vivo models.
The proposed research will provide new significant insight into characterization of mechanisms
underlying Cul4A-mediated Th2-type tolerance that may potentially have therapeutic implications for
allergic diseases.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roza Insafetdinovna Nurieva其他文献
Roza Insafetdinovna Nurieva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roza Insafetdinovna Nurieva', 18)}}的其他基金
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
检查点抑制剂引起的免疫相关毒性的基于机制的治疗策略
- 批准号:
10753628 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance
E3 泛素连接酶 RNF133 在 T 细胞功能和耐受性中的作用
- 批准号:
10311074 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Role of Cul4A in Governing Th2-Type Tolerance
Cul4A 在控制 Th2 型耐受中的作用
- 批准号:
9770641 - 财政年份:2018
- 资助金额:
$ 40万 - 项目类别:
Grail-targeting breaks the immune tolerance to melanoma
圣杯靶向打破了对黑色素瘤的免疫耐受
- 批准号:
9379209 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
STAT1: New regulator of inflammatory Th17 and Th2 cells
STAT1:炎症 Th17 和 Th2 细胞的新调节因子
- 批准号:
9112386 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
STAT1: New regulator of inflammatory Th17 and Th2 cells
STAT1:炎症 Th17 和 Th2 细胞的新调节因子
- 批准号:
9206467 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
Role of Grail in maintaining humoral immune tolerance
Grail 在维持体液免疫耐受中的作用
- 批准号:
9089880 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Regulation of T cell activation and tolerance by Grail
Grail 对 T 细胞活化和耐受的调节
- 批准号:
8468985 - 财政年份:2009
- 资助金额:
$ 40万 - 项目类别:
Regulation of T cell activation and tolerance by Grail
Grail 对 T 细胞活化和耐受的调节
- 批准号:
7869435 - 财政年份:2009
- 资助金额:
$ 40万 - 项目类别:
Regulation of T cell activation and tolerance by Grail
Grail 对 T 细胞活化和耐受的调节
- 批准号:
7700519 - 财政年份:2009
- 资助金额:
$ 40万 - 项目类别:
相似海外基金
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center
气道疾病暴露组分析以解开哮喘疾病的决定因素 (EXPAND-Asthma) 中心
- 批准号:
10744673 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
- 批准号:
10723956 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
定义气道疾病、COPD 恶化和治疗反应的基因表达特征
- 批准号:
10733573 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Impact of Maternal Arsenic Exposure on Offspring's Epigenetic Reprogramming of Allergic Airway Disease
母亲砷暴露对后代过敏性气道疾病表观遗传重编程的影响
- 批准号:
10733607 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10716654 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Immune Mediators of IL-22 Signaling Alter Allergic Airway Disease
IL-22 信号的免疫介质改变过敏性气道疾病
- 批准号:
10853347 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress
假单胞菌脂质 A 结构在 CF 气道疾病进展中的微生物适应
- 批准号:
10722599 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
The role of anaerobic microbiota in cystic fibrosis airway disease trajectory
厌氧微生物群在囊性纤维化气道疾病轨迹中的作用
- 批准号:
10985906 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Mentoring patient-oriented researchers in inflammatory airway disease
指导炎症性气道疾病领域以患者为中心的研究人员
- 批准号:
10657746 - 财政年份:2022
- 资助金额:
$ 40万 - 项目类别:














{{item.name}}会员




